ArticleEndocrinology and metabolism (Seoul, Korea)2021

Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes.

Jang Won SonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.